United States - English - NLM (National Library of Medicine)

gemini pharmaceuticals, inc. dba plus pharma - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 500 mg - antacid for the relief of - heartburn - sour stomach - acid indigestion - upset stomach associated with these symptoms

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - calcium carbonate,colecalciferol,risedronate sodium -

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - calcium carbonate (unii: h0g9379fgk) (carbonate ion - unii:7ujq5ope7d) - calcium carbonate 750 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - calcium carbonate,colecalciferol,risedronate sodium -

Ireland - English - HPRA (Health Products Regulatory Authority)

takeda products ireland ltd - calcium carbonate; cholecalciferol concentrate (powder form) - chewable tablet - 1000/800 mg/iu - calcium, combinations with vitamin d and/or other drugs

United States - English - NLM (National Library of Medicine)

wg critical care, llc - calcium gluconate monohydrate (unii: czn0mi5r31) (calcium cation - unii:2m83c4r6zb) - calcium gluconate in sodium chloride injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. limitations of use the safety of calcium gluconate in sodium chloride injection for long term use has not been established. calcium gluconate in sodium chloride injection is contraindicated in: •hyperca lcemia • neonates (28 days of age or younger) receiving ceftriaxone [see warnings and precautions (5.2)] risk summary limited available data with calcium gluconate injection use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. there are risks to the mother and the fetus associated with hypocalcemia in pregnancy [see clinical considerations] . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respecti

Ireland - English - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - calcium carbonate; cholecalciferol concentrate (powder form) - chewable tablet - 1000/800 mg/iu - calcium, combinations with vitamin d and/or other drugs

Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - calcium carbonate - chewable tablets - calcium carbonate 1000 mg - calcium carbonate - calcium carbonate - for relief from heartburn and acidity.

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline consumer healthcare (ireland) limited - calcium carbonate, colecalciferol - tablets effervescent - 600 mg + 400 iu base milligrams - calcium, combinations with other drugs

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - calcium gluconate monohydrate, quantity: 95.3 mg/ml - injection, solution - excipient ingredients: calcium saccharate; water for injections - calcium gluconate is a calcium salt used primarily for the prevention and treatment of calcium deficiency. parenteral administation of calcium gluconate is needed in acute hypocalcaemia and hypocalcsemic tetany. it can be given intravenously in the treatment of severe hyper-kalaemia and in overdosage of magnesium sulphate, as calcium is the antagonist of magnesium toxicity. iv injections have been used in the treatment of acute renal biliary and intestinal colic. calcium has been used as an inotrope in cardiac resuscitation. they may also be used for the prevention of hypocalcaemia in exchange transfusions, and in long term electrolyte replacement therapy.